1. Patient Characteristics Compete with Dose as Predictors of Acute Treatment Toxicity in Early Phase Clinical Trials
   André Rogatko et al, 2004, Clinical Cancer Research CrossRef
2. Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
   Gürkan Güner et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef